Active
TERM 2
February 14, 2025 · 425 days ago
📚 Education
On February 14, 2025, Executive Order 14214 was signed directing the elimination of COVID-19 vaccine mandates in schools. The order removes federal requirements and guidance that schools mandate COVID-19 vaccination as a condition of attendance or employment. The confirmed direct impact is that schools receiving federal funding are no longer required to enforce COVID-19 vaccine mandates, though individual states and school districts retain authority to establish their own policies.
Active
TERM 1
January 27, 2025 · 443 days ago
🏥 Healthcare
On January 27, 2025, President Trump signed Executive Order 14184 directing the reinstatement of service members who were discharged under the military's COVID-19 vaccination mandate. The order requires the Department of Defense to reinstate affected service members and may provide back pay and benefits restoration. The confirmed direct impact includes restoring military status and pay for service members previously separated from the armed forces.
Expired
TERM 1
June 24, 2020 · 2,121 days ago
🏥 Healthcare
On June 24, 2020, the Trump administration issued a Presidential Determination under Section 303 of the Defense Production Act of 1950, invoking authority to prioritize defense contracts related to COVID-19 vaccine manufacturing. The determination authorized the government to allocate materials and resources to vaccine production facilities. The confirmed effect was to establish priority rating authority for contracts supporting vaccine development and manufacturing capacity during the pandemic.
Active
TERM 1
September 19, 2019 · 2,400 days ago
🏥 Healthcare
Executive Order 13887 was signed on September 19, 2019, directing federal agencies to modernize influenza vaccine development and manufacturing to improve effectiveness and reduce production timelines. The order established a task force to accelerate development of next-generation flu vaccines and streamline regulatory approval processes. The confirmed direct impact includes accelerated research funding and regulatory pathways for influenza vaccine innovation, though widespread deployment of modernized vaccines occurred after the order's implementation period.